Nano-X Imaging Ltd. (NASDAQ:NNOX) earns a place on our list of the most popular AI penny stocks to buy.
A technician in a lab coat inspecting an X-ray imaging component.
With distribution partnerships and deployment agreements beginning to translate into measurable commercial traction, Nano-X Imaging Ltd. (NASDAQ:NNOX) appears to be marking its entry into a scaled, partner-driven rollout phase.
Nanox Impact Inc., the company’s subsidiary, penned a new U.S. distribution agreement on May 4, 2026, with NuvioDx LLC to accelerate deployment of its FDA-cleared Nanox.ARC medical imaging systems across multiple U.S. clinical sites. Nanox will leverage NuvioDx’s assistance in the deployment of the Nanox.ARC multi-source digital tomosynthesis system, designed to provide lower-cost 3D imaging with reduced radiation exposure compared with conventional CT imaging.
That system will provide access to medical imaging services to more people and will help hospitals operate more efficiently. At the same time, management expects the system’s enablement of improved diagnosis to lead to better patient outcomes.
The agreement will help Nano-X Imaging Ltd. (NASDAQ:NNOX) reach additional markets by relying on partners who already have strong local networks. That reinforces the company’s strategy to grow through a channel-led model.
A large-scale commercial agreement was signed by the company prior to that deal, reinforcing its shift toward partner-led commercialization and leveraging a wide-reaching sales network.
Nano-X Imaging Ltd. (NASDAQ:NNOX) partnered with Howard Technology Solutions to install 300 Nanox.ARC systems for over three years. The company expects to deploy 60 machines in year one across hospitals and the public sector.
Meanwhile, the performance in 2025 provided Nano-X Imaging Ltd. (NASDAQ:NNOX) with a solid foundation.
The last quarter of the year saw continued deployment progress, with approximately 36 systems in various stages of installation or use, and agreements already signed for approximately 360 machines to be purchased, with deployments expected over the next two to three years. On the back of that momentum, management stuck to its forecast of earning $35 million in 2026.
Nano-X Imaging Ltd. (NASDAQ:NNOX) engages in the development of medical imaging systems across Nanox.ARC, AI solutions, and radiology services. With those specialties, the company offers cloud-based diagnostics, AI tools, and radiology connectivity.
While we acknowledge the risk and potential of NNOX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NNOX and that has 10,000% upside potential, check out our report about this cheapest AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. Follow Insider Monkey on Google News.
